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METHODS: The study used data from the BAUS registry, a mandatory databse which records information on all PCNLs performed, for 2014 and 2015. Details were retrieved from the highest quartile volume surgeons and compared to the lowest quartiule volume surgeons. A series of comparisons of outcomes was then made between the high volume and the low volume groups. These outcomes included clearance on imaging at day one, blood transfusion, sepsis, complcations and post-operative length of stay. These comparisons were made for all stones accoridng to their Guys Stone Score (GSS) complexity, graded from 1-4. Comparisons were carried out using Fishers exact test.
RESULTS: 4035 PCNL were recorded. Those surgeons in the lower quartile performed 5 and 4 PCNLs or less in 2014 and 2015 respectively, and those in the upper quartile over 18 and 17 in the same time frames. Overall stone clearance, by imaging at day one, was higher in the higher volume surgeons for GSS1 (93% v 80%, p¼0.01), GSS2 (74% v 63%, p¼0.01), GSS3 (66% v 50%) and GSS 4 stones (37% v 35%, p¼0.41), although not significantly for the latter. There was no difference in post op transfusion rates or sepsis. Conplication rates were higher for lower volume surgeons (9.6% v 4.7%, p¼0.009).
CONCLUSIONS: Lower volume surgeons have higher complcations rates and lower stone free rates after PCNL. RESULTS: A total of 159 ureteroscopy procedures were performed, which included 184 renal units. Mean operative time was 61 minutes (standard deviation 34.8 minutes). Ureteroscopy was performed for treatment of 40 ureteral stones (mean diameter 7.6 mm), 119 renal stones (mean diameter 12.2 mm), 6 ureteral tumors, and 5 renal pelvis tumors. Ureteral access sheath was used for 53.8% of renal units, and ureteral stent was left in 77% of renal units. There were no major surgical complications. There was 1 case of technical equipment failure (image disappeared, surgeon changed to reusable ureteroscope), 3 cases of failure to reach a stone (2 lower pole, 1 calyceal diverticulum). Electrocautery artifact of the digital image limiting use of electrocautery was noted during 2 procedures for urothelial carcinoma.
Source of
CONCLUSIONS: LithoVueÔ Single-use Digital Flexible Ureteroscope was used successfully in this initial clinical series of over 150 cases. In this pilot study, procedure failure rate was not inferior to reported rates of failure for reusable ureteroscopes. This study looks at differences in management and outcomes of patients with two subsets of stones: those under 1cm compared to all other stones and staghorn stones compared to all others treated by PCNL.
METHODS: The registry was analysed for stone characteristics (stones up to 1cm, staghorn stones and all others), procedure details and outcomes (complications and stone free rates) for the two year period period January 2014 -December 2015. The fisher test was used for statistical analysis except for length of stay (LOS) which used confidence interval analysis.
RESULTS: A total of 4166 procedures were performed by 183 UK surgeons (median number 17) over this time period. Of these 404 (9%) were for stones <1cm and 600 (14%) for staghorn stones. All other stones accounted for the remaining 3162. Females were more likely to have a staghorn stone (p < 0.01). Larger amplatz sheath sizes (27chþ) were used for staghorn stones (78% vs 29 % for smaller stones p<0.01). Staghorn stones were more likely to have a postprocedure nephrostomy tube (78% vs 69% for smaller stones, p<0.05) whereas stones <1cm were less likely to have a post-operative nephrostomy tube (p < 0.01). Overall intra-operative and post operative complications lower in the stones <1cm group (<0.05) where as these were higher in the staghorn group (sepsis p < 0.01 and transfusion rates p ¼ 0.04) compared to all other stones. There was no difference in more severe (Clavien IIIþ) complications in any of the stone size groups. LOS was significantly shorter for stones <1cm (mean LOS 3.09 days) and longer for staghorn stones (mean LOS 4.71 days). Stone free rates were as stones <1cm were as follows: 72.5% on fluoroscopic imaging and 77% on imaging at follow up. Stone free rates for staghorn stones were 44.8% on fluoroscopic imaging and 46.9% on imaging at follow up.
CONCLUSIONS: Around 10% of PCNLs in the UK between Jan 2014 and Dec 2015 were done for small stones <1cm. Excellent stone free rates are achieved with few complications. It is expected that with miniturisation techniques, PCNL for small stones will continue to be utilised as an effective treatment option. 14% of all PCNLs performed in the UK were for staghorn stones. PCNL for staghorn stones was less likely to achieve complete stone clearance compared to other stone sizes (p < 0.01). Complications were higher in the staghorn stone group compared to PCNLs for smaller stone sizes and overall length of stay was longer.
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